Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, Week Ending September 14, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Fulcrum Equity Partners Life of Purpose Treatment Centers N/A 360 Behavioral Health Passport to Adaptive Living N/A Biotechnology Acquirer Target Price Allergan plc Bonti, Inc. $195 million Boehringer Ingelheim... Read More »
DW Healthcare Partners Exits Rehab and Enters Behavioral Health
DW Healthcare Partners has had a busy summer, buying a healthcare staffing company and a behavioral health platform, then selling its rehabilitation business. In June, the firm announced its investment in Aequor Healthcare Services in Piscataway, New Jersey, the sixth investment made by DW Healthcare Partners Fund IV, LP. Aequor specializes in healthcare and clinical staffing by providing physicians, therapists, nurses, technologists and allied healthcare professionals to hospital systems, nursing homes, home care providers, clinics, school systems, laboratories, and pharmaceutical/life sciences organizations nationwide. In August, it acquired California Psychcare, a behavioral services... Read More »
Welltok Strikes Again, Buying WellPass
Welltok, a portfolio company of New Enterprise Associates since 2013, has boosted its consumer health platform, CafeWell, with the acquisition of WellPass. WellPass was formed in 2017 through the merger of Sense Health and Voxiva. The latter worked with many large payers and organizations on mobile and digital health products. Sense Health focuses on Medicaid care managers. Wellpass has created interactive, popular text-based programs such as Text4Baby, Text2Quit and Care4Life, and works with a roster of Medicaid plans, state Medicaid agencies and departments of health, as well as providers and pharmaceutical companies. The acquisition will allow Wellpass’ current clients to more... Read More »
Allergan Doubles Down on Aesthetics
September 14 was a big day for Allergan plc’s (NYSE: AGN) medical aesthetics business. The company announced its acquisition of Bonti, Inc., a privately held clinical-stage biotech that develops novel, fast-acting neurotoxin programs for aesthetic and therapeutic applications. Later that same day, Allergan hosted a Medical Aesthetics Day in New York, at which its chief commerical officer, Bill Meury, said the company expects the unit to generate between $7 billion and $8 billion in sales by 2025. The business unit generated $3.8 billion in 2017. Allergan’s Medical Aesthetics unit includes the famous neurotoxin Botox (onabotulinumtoxinA), which was first approved in 1989 and... Read More »
Health Care M&A Deals, Week Ending September 7, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price United Therapeutics Corp. Collaboration on pulmonary hypertension products $45 million Kwang Dong Pharmaceutical Co., Ltd. License to ATB-346 $9.8 million Biohaven Pharmaceutical Holding Company Ltd. License to AZD3241 N/A Shire plc Sanaplasma AG N/A... Read More »
Summertime Sales from Novartis
It’s been a busy summer for Novartis AG (NYSE: NVS). The Swiss drug-maker has sold off a few assets, one at a loss. On August 31, Mylan NV (NYSE: MYL) acknowledged that it paid $463 million for Novartis’ cystic fibrosis products. Novartis sold the worldwide rights to commercialize its cystic fibrosis products TOBI Podhaler (tobramycin inhalation powder) and TOBI (tobramycin solution for inhalation). Mylan expects to pay $240 million this year, with the rest coming later. Then on September 6, Novartis announced the sale of certain assets in its Sandoz U.S. portfolio, specifically the Sandoz dermatology business and generic oral solids portfolio. It comprises approximately 300... Read More »
Long-Term Care Deals Soared in August
As temperatures soared this summer, so did the dealmaking in the Long-Term Care sector. On the back of a solid July (27 deals total), August shattered the previous record-high of 37 announced deals for the month set in 2015 and the 27 deals recorded in August 2017 with an astonishing, and still-growing, 46 transactions. That puts the third quarter on track to most likely top Q3:15’s 99 deals for the sector. What has gotten into buyers this summer? Riding a wave of high consumer confidence and low interest rates, and in the face of numerous industry headwinds, investors are still confident in seniors housing and care properties to provide their desired returns. That is coupled with plenty... Read More »
August 2018 Sets New Record for Health Care Deals
Did any of you deal makers take a vacation last month? I know for a fact that many of you did, but the pace of deal announcements didn’t slow for a moment in August 2018. Deal volume reached 144 and still counting, a new record for the month. The total got a boost from a suddenly hot Long-Term Care sector, which logged 46 transactions. That’s a 70% boost compared with the 27 deals reported in both July 2018 and August 2017. Looking back through our database, August has been fairly quiet for the past 20 years, as far as deal volume is concerned. Way back in August 1997, 113 transactions were announced, and that was before we began tracking the technology sectors—Biotechnology, eHealth,... Read More »
Health Care M&A Deals, Week Ending August 31, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Genentech, Inc. Collaboration on immunotherapeutics $96 million eHealth Acquirer Target Price Alliance MMA, Inc. SCWorx Corp. $50 million True Nature Holding, Inc. ClariCare, Inc. $3 million Harris Healthcare Iatric Systems, Inc. N/A Laboratories, MRI... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
